Accolade ACCD 深 沪
等待开盘 04-02 09:30:00 美东时间
7.02
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 7.02
- 总市值 5.76亿
- 52周最高 9.67
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 3.08
- 委 比 0.00%
- 总股本 8199.31万
- 历史最高 65.25
- 量 比 0
- 振 幅 0.00%
- 历史最低 3.08
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Moomoo and the New York Mets Enter Second Year of Strategic Partnership to Continue Enhancing the Fan Experience
<p>Moomoo, a leading global investment platform, has entered its second year of partnership with the New York Mets, connecting baseball fans and investors through shared passion for performance. Activities include suite experiences, enhanced in-stadium events, and sweepstakes this season. Both parties expressed excitement over last year’s success and look forward to creating more memorable moments.</p>
03-27 16:00
Maye Musk Says Foundation Of Love Shaped Elon After Tesla Co-Founder Says He Agrees With 'Teachings Of Jesus'
Maye Musk shares her message of universal kindness and religious diversity while celebrating her son Elon's innovation accolades and genius.
02-20 12:10
ACCO GROUP HOLDINGS LIMITED ANNOUNCES PARTIAL EXERCISE OF UNDERWRITERS’ OVER-ALLOTMENT OPTION
ACCO Group Holdings Limited, a corporate service provider based in Hong Kong, announced the partial exercise of the over-allotment option by underwriters, resulting in the sale of an additional 49,900 ordinary shares at US$4.00 each. The total shares sold in the Offering increased to 1,449,900, raising approximately US$5.80 million. The net proceeds will be used for expanding the corporate service business, integrating generative AI, establishing...
2025-11-19 21:15
Accolade Completes Merger, Plans Nasdaq Delisting
An update from Accolade ( ($ACCD) ) is now available. Accolade has announced th...
2025-04-08 22:14
Accolade Announces That Stockholders Voted To Approve Merger With Transcarent
Accolade (NASDAQ:ACCD) announced that Accolade stockholders voted to approve the merger with Transcarent at the Accolade special meeting of stockholders (the "Special Meeting") held earlier today. The final, certified
2025-03-28 04:10
Accolade Welcomes Oshi Health to Trusted Partner Ecosystem
Partnership increases access to specialized, whole-person clinical care for people managing digestive health conditions SEATTLE, March 6, 2025 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) h...
2025-03-06 22:00
U.S. RESEARCH ROUNDUP-Accolade, CrowdStrike, Marriott International
March 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Accolade, Crowdstrike and Marriott International, on Wednesday. ...
2025-03-05 15:53
BRIEF-FDA Boston Scientific Corporation Recalls Accolade Pacemaker Devices Due To Manufacturing Issue That May Lead To Early Device Replacement
Feb 21 (Reuters) - FDA: FDA: BOSTON SCIENTIFIC CORPORATION RECALLS ACCOLADE PACEMAKER DEVICES DUE TO A MANUFACTURING ISSUE THAT MAY LEAD TO EARLY DEVICE REPLACEMENT FDA: IDENTIFIED BOSTON SCIENTIFIC'S...
2025-02-22 02:45
Stephens & Co. Reiterates Equal-Weight on Accolade, Maintains $7.03 Price Target
Stephens & Co. analyst Jeff Garro reiterates Accolade (NASDAQ:ACCD) with a Equal-Weight and maintains $7.03 price target.
2025-02-12 23:15
